Compugen Stock

Compugen Net Margin

Delisted·Jun 15, 2026

The Net Profit Margin of Compugen (CGEN) as of Jul 15, 2026 is 48.57 %. In the previous year, Net Profit Margin was -51.07 % — a change of -195.10% (higher).

Net Margin

48.57 %

YoY

-195.10%

Last updated:

Net Profit Margin of Compugen is 2026 48.57 % . Net Profit Margin of Compugen was 2025 -51.07 % . It decreases by -195.10% higher compared to the previous year.

For Compugen, the net margin of 48.6% is up versus -570.0% a few years ago.

Access this data via the Eulerpool API

Compugen Stock analysis

What does Compugen do? Compugen Ltd is an Israeli biotechnology company focused on the development of therapeutics and diagnostic products. It was founded in 1993 and is headquartered in Tel Aviv. Compugen is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Compugen stock

Net Profit Margin of Compugen is 48.57 % in 2026.

Access this data via the Eulerpool API

Margins — Compugen

All Key Metrics — Compugen